Increased Risk of Surgical Aortic Valve Replacement After Prior Transcatheter Versus Surgical Aortic Valve Replacement with Concomitant Valve Disease.

IF 3.6 2区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

Annals of Thoracic Surgery Pub Date : 2025-01-21 DOI:10.1016/j.athoracsur.2025.01.005

Robert B Hawkins, Barbara C S Hamilton, Devraj Sukul, G Michael Deeb, Gorav Ailawadi, Shinichi Fukuhara

{"title":"Increased Risk of Surgical Aortic Valve Replacement After Prior Transcatheter Versus Surgical Aortic Valve Replacement with Concomitant Valve Disease.","authors":"Robert B Hawkins, Barbara C S Hamilton, Devraj Sukul, G Michael Deeb, Gorav Ailawadi, Shinichi Fukuhara","doi":"10.1016/j.athoracsur.2025.01.005","DOIUrl":null,"url":null,"abstract":"Background: The etiology of increased risk for reoperation after transcatheter aortic valve replacement (TAVR) versus prior surgical aortic valve replacement (SAVR) is poorly understood. This study evaluated the impact of concomitant mitral and tricuspid valve disease on associated risk of TAVR explant.Methods: Patients undergoing aortic valve replacement after prior SAVR or TAVR were extracted from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (2011-2021). Patients were stratified by TAVR explant status and presence of severe concomitant valve disease for analyses. Risk adjustment was performed using multivariable logistic regression. Interaction terms were utilized to evaluate differential risk of concomitant valve disease for TAVR explant versus redo-SAVR.Results: Of 24,097 redo aortic valve replacement patients, 877 (3.6%) underwent TAVR explant. TAVR explant patients had higher rates of concomitant severe valve disease (17% vs 14%, p<0.001). Patients with severe concomitant valve disease had worse operative mortality after TAVR explant (26.2% vs 14.6%, p<0.001) and redo-SAVR (12.3% vs 6.9%, p<0.001). TAVR explant was independently associated with higher mortality (ORadj 1.3 [1.0-1.6], p=0.030). Severe mitral regurgitation (ORadj 1.2 [1.0-1.6], p=0.017), mitral stenosis (ORadj 2.0 [1.5-2.7, p<0.001), and tricuspid regurgitation (ORadj 1.6 [1.3-1.9], p<0.001) were all associated with mortality, although these factors were not associated with disproportionately higher risk during TAVR explant (p>0.05).Conclusions: TAVR explant cases have a higher burden of severe concomitant valve disease than redo-SAVR cases. Heart teams should consider these findings when discussing initial procedure choices for patients with multi-valve disease given their extreme risk at time of TAVR explant.","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.6000,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Thoracic Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.athoracsur.2025.01.005","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Background: The etiology of increased risk for reoperation after transcatheter aortic valve replacement (TAVR) versus prior surgical aortic valve replacement (SAVR) is poorly understood. This study evaluated the impact of concomitant mitral and tricuspid valve disease on associated risk of TAVR explant.

Methods: Patients undergoing aortic valve replacement after prior SAVR or TAVR were extracted from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (2011-2021). Patients were stratified by TAVR explant status and presence of severe concomitant valve disease for analyses. Risk adjustment was performed using multivariable logistic regression. Interaction terms were utilized to evaluate differential risk of concomitant valve disease for TAVR explant versus redo-SAVR.

Results: Of 24,097 redo aortic valve replacement patients, 877 (3.6%) underwent TAVR explant. TAVR explant patients had higher rates of concomitant severe valve disease (17% vs 14%, p<0.001). Patients with severe concomitant valve disease had worse operative mortality after TAVR explant (26.2% vs 14.6%, p<0.001) and redo-SAVR (12.3% vs 6.9%, p<0.001). TAVR explant was independently associated with higher mortality (OR_adj 1.3 [1.0-1.6], p=0.030). Severe mitral regurgitation (OR_adj 1.2 [1.0-1.6], p=0.017), mitral stenosis (OR_adj 2.0 [1.5-2.7, p<0.001), and tricuspid regurgitation (OR_adj 1.6 [1.3-1.9], p<0.001) were all associated with mortality, although these factors were not associated with disproportionately higher risk during TAVR explant (p>0.05).

Conclusions: TAVR explant cases have a higher burden of severe concomitant valve disease than redo-SAVR cases. Heart teams should consider these findings when discussing initial procedure choices for patients with multi-valve disease given their extreme risk at time of TAVR explant.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Annals of Thoracic Surgery 医学-呼吸系统

CiteScore

6.40

自引率

13.00%

发文量

1235

审稿时长

42 days

期刊介绍： The mission of The Annals of Thoracic Surgery is to promote scholarship in cardiothoracic surgery patient care, clinical practice, research, education, and policy. As the official journal of two of the largest American associations in its specialty, this leading monthly enjoys outstanding editorial leadership and maintains rigorous selection standards. The Annals of Thoracic Surgery features: • Full-length original articles on clinical advances, current surgical methods, and controversial topics and techniques • New Technology articles • Case reports • "How-to-do-it" features • Reviews of current literature • Supplements on symposia • Commentary pieces and correspondence • CME • Online-only case reports, "how-to-do-its", and images in cardiothoracic surgery. An authoritative, clinically oriented, comprehensive resource, The Annals of Thoracic Surgery is committed to providing a place for all thoracic surgeons to relate experiences which will help improve patient care.